Company: SABR
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001628280-25-049383
Chunk: 169

Company: Sabre Corp
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 8
Chunk 169
---
 The fair value of our investment in GBT was based on its share price, a Level 1 input, as the stock is publicly traded on the New York Stock Exchange under the symbol GBTG. In the third quarter of 2024, we sold all 8 million shares of our investment for $55 million and recognized a net gain of $3 million for the year ended December 31, 2024. Unrealized losses recognized during the three and nine months ended September 30, 2024 from our investments in securities were not material.The following tables present our assets (liabilities) that are required to be measured at fair value on a recurring basis as of September 30, 2025 and December 31, 2024 (in thousands): Fair Value at Reporting Date UsingAssets:September 30, 2025Level 1Level 2Level 3Money market funds$392,887 $392,887 $— $— Time deposits30,001 — 30,001 — Investment in securities517 517 — — Total assets$423,405 $393,404 $30,001 $— Liabilities:Derivatives(1)Interest rate swap contracts$(1,961)$— $(1,961)$— Total liabilities$(1,961)$— $(1,961)$—  Fair Value at Reporting Date UsingAssets:December 31, 2024Level 1Level 2Level 3Money market funds$425,407 $425,407 $— $— Time deposits78,595 — 78,595 — Investment in securities555 555 — — Total assets$504,557 $425,962 $78,595 $— Liabilities:Derivatives(1)Interest rate swap contracts$(2,266)$— $(2,266)$— Total liabilities$(2,266)$— $(2,266)$— ______________________(1) See Note 8. Derivatives for further detail.There were no transfers between Levels 1 and 2 within the fair value hierarchy for the three and nine months ended September 30, 2025.Other Financial InstrumentsThe carrying value of our financial instruments including cash and cash equivalents, restricted cash and accounts receivable approximates their fair values due to the short term nature of these instruments. The fair values of our